Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


PROTIA, LLC

PROTIA, LLC Patent applications
Patent application numberTitlePublished
20120035261DEUTERIUM-ENRICHED SAXAGLIPTIN - The present application describes deuterium-enriched saxagliptin, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.02-09-2012
20120035227DEUTERIUM-ENRICHED IXABEPILONE - The present application describes deuterium-enriched ixabepilone, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.02-09-2012
20120015956DEUTERIUM-ENRICHED DASATINIB - The present application describes deuterium-enriched dasatinib, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.01-19-2012
20110312983DEUTERIUM-ENRICHED ALOGLIPTIN - The present application describes deuterium-enriched alogliptin, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.12-22-2011
20110281952DEUTERIUM-ENRICHED TOLTERODINE - The present application describes deuterium-enriched tolterodine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.11-17-2011
20110281927DEUTERIUM-ENRICHED DORIPENEM - The present application describes deuterium-enriched doripenem, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.11-17-2011
20110212976DEUTERIUM-ENRICHED RISPERIDONE - The present application describes deuterium-enriched risperidone, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.09-01-2011
20110201690DEUTERIUM-ENRICHED DAPOXETINE - The present application describes deuterium-enriched dapoxetine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.08-18-2011
20110160270DEUTERIUM-ENRICHED SDX-101 - The present application describes deuterium-enriched SDX-101, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.06-30-2011
20110144174DEUTERIUM-ENRICHED ODANSETRON - The present application describes deuterium-enriched ondansetron, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.06-16-2011
20110130463DEUTERIUM-ENRICHED BUPROPION - The present application describes deuterium-enriched bupropion, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.06-02-2011
20110124732DEUTERIUM-ENRICHED DISUFENTON - The present application describes deuterium-enriched disufenton, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.05-26-2011
20110124704DEUTERIUM-ENRICHED ATORVASTATIN - The present application describes deuterium-enriched atorvastatin, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.05-26-2011
20110118358DEUTERIUM-ENRICHED SALMETEROL - The present application describes deuterium-enriched salmeterol, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.05-19-2011
20110046236ALCOHOLIC COMPOSITIONS HAVING A LOWERED RISK OF ACETALDEHYDEMIA - The present invention provides beverages and pharmaceutical compositions containing a deuterated alcohol according to Formula 1, and provides methods for their manufacture and use.02-24-2011
20110046082DEUTERIUM-ENRICHED NELARABINE - The present application describes deuterium-enriched nelarabine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.02-24-2011
20110039872DEUTERIUM-ENRICHED CAPECITABINE - The present application describes deuterium-enriched capecitabine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.02-17-2011
20110028454DEUTERIUM-ENRICHED BAZEDOXIFENE - The present application describes deuterium-enriched bazedoxifene, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.02-03-2011
20100081720DEUTERIUM-ENRICHED ATOMOXETINE - The present application describes deuterium-enriched atomoxetine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.04-01-2010
20100029592DEUTERIUM-ENRICHED FOSAPREPITANT - The present application describes deuterium-enriched fosaprepitant, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.02-04-2010
20090306215DEUTERIUM-ENRICHED ARFORMOTEROL - The present application describes deuterium-enriched arformoterol, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.12-10-2009
20090215802DEUTERIUM-ENRICHED LAPATINIB - The present application describes deuterium-enriched lapatinib, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.08-27-2009
20090209608DEUTERIUM-ENRICHED ASENAPINE - The present application describes deuterium-enriched asenapine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.08-20-2009
20090156671DEUTERIUM-ENRICHED OXYBUTYNIN - The present application describes deuterium-enriched oxybutynin, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.06-18-2009
20090118238DEUTERIUM-ENRICHED ALENDRONATE - The present application describes deuterium-enriched alendronate sodium, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.05-07-2009
20090105338DEUTERIUM-ENRICHED GABEXATE MESYLATE - The present application describes deuterium-enriched gabexate mesylate, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.04-23-2009
20090088416DEUTERIUM-ENRICHED LAPAQUISTAT - The present application describes deuterium-enriched lapaquistat, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.04-02-2009
20090082471DEUTERIUM-ENRICHED FINGOLIMOD - The present application describes deuterium-enriched fingolimod, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-26-2009
20090082469DEUTERIUM-ENRICHED TERBINAFINE - The present application describes deuterium-enriched terbinafine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-26-2009
20090082468DEUTERIUM-ENRICHED LEVALBUTEROL - The present application describes deuterium-enriched levalbuterol, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-26-2009
20090082465DEUTERIUM-ENRICHED LISDEXAMFETAMINE - The present application describes deuterium-enriched lisdexamfetamine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-26-2009
20090082462DEUTERIUM-ENRICHED ARMODAFINIL - The present application describes deuterium-enriched amodafinil, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-26-2009
20090082461DEUTERIUM-ENRICHED MODAFINIL - The present application describes deuterium-enriched modafinil, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-26-2009
20090082459DEUTERIUM-ENRICHED GUANFACINE - The present application describes deuterium-enriched guanfacine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-26-2009
20090082458DEUTERIUM-ENRICHED ALISKIREN - The present application describes deuterium-enriched aliskiren, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-26-2009
20090082454DEUTERIUM-ENRICHED DISUFENTON - The present application describes deuterium-enriched disufenton, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-26-2009
20090082452DEUTERIUM-ENRICHED LUMIRACOXIB - The present application describes deuterium-enriched lumiracoxib, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-26-2009
20090082450DEUTERIUM-ENRICHED DICLOFENAC - The present application describes deuterium-enriched diclofenac, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-26-2009
20090082442DEUTERIUM-ENRICHED LUBIPROSTONE - The present application describes deuterium-enriched lubiprostone, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-26-2009
20090082441DEUTERIUM-ENRICHED TESAGLITAZAR - The present application describes deuterium-enriched tesaglitazar, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-26-2009
20090082436DEUTERIUM-ENRICHED RIVASTIGMINE - The present application describes deuterium-enriched rivastigmine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-26-2009
20090082432DEUTERIUM-ENRICHED RAMELTEON - The present application describes deuterium-enriched ramelteon, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-26-2009
20090082422DEUTERIUM-ENRICHED LEVETIRACETAM - The present application describes deuterium-enriched levetiracetam, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-26-2009
20090082420DEUTERIUM-ENRICHED VILDAGLIPTIN - The present application describes deuterium-enriched vildagliptin, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-26-2009
20090082419DEUTERIUM-ENRICHED TEGASEROD - The present application describes deuterium-enriched tegaserod, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-26-2009
20090082418DEUTERIUM-ENRICHED FLUVASTATIN - The present application describes deuterium-enriched fluvastatin, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-26-2009
20090082417DEUTERIUM-ENRICHED SDX-101 - The present application describes deuterium-enriched SDX-101, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-26-2009
20090082416DEUTERIUM-ENRICHED BENDAMUSTINE - The present application describes deuterium-enriched bendamustine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-26-2009
20090082414DEUTERIUM-ENRICHED VIRAMIDINE - The present application describes deuterium-enriched viramidine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-26-2009
20090082413DEUTERIUM-ENRICHED LETROZOLE - The present application describes deuterium-enriched letrozole, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-26-2009
20090082412DEUTERIUM-ENRICHED DEFERASIROX - The present application describes deuterium-enriched deferasirox, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-26-2009
20090082405DEUTERIUM-ENRICHED PIOGLITAZONE - The present application describes deuterium-enriched pioglitazone, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-26-2009
20090082401DEUTERIUM-ENRICHED TIAGABINE - The present application describes deuterium-enriched tiagabine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-26-2009
20090082387DEUTERIUM-ENRICHED NVP-BEZ234 - The present application describes deuterium-enriched NVP-BEZ235, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-26-2009
20090082385DEUTERIUM-ENRICHED DESLORATIDINE - The present application describes deuterium-enriched desloratadine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-26-2009
20090082383DEUTERIUM-ENRICHED BUPRENORPHINE - The present application describes deuterium-enriched buprenorphine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-26-2009
20090082382DEUTERIUM-ENRICHED NALTREXONE - The present application describes deuterium-enriched naltrexone, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-26-2009
20090082380DEUTERIUM-ENRICHED ROSUVASTATIN - The present application describes deuterium-enriched rosuvastatin, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-26-2009
20090082376DEUTERIUM-ENRICHED ALOGLIPTIN - The present application describes deuterium-enriched alogliptin, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-26-2009
20090082366DEUTERIUM-ENRICHED TELAPREVIR - The present application describes deuterium-enriched telaprevir, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-26-2009
20090082364DEUTERIUM-ENRICHED LEVOCEDTIRIZINE - The present application describes deuterium-enriched levocetirizine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-26-2009
20090082363DEUTERIUM-ENRICHED POSACONAZOLE - The present application describes deuterium-enriched posaconazole, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-26-2009
20090082361DEUTERIUM-ENRICHED IMATINIB - The present application describes deuterium-enriched imatinib, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-26-2009
20090082335DEUTERIUM-ENRICHED OXCARBAZEPINE - The present application describes deuterium-enriched oxcarbazepine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-26-2009
20090082334DEUTERIUM-ENRICHED QUETIAPINE - The present application describes deuterium-enriched quetiapine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-26-2009
20090082327DEUTERIUM-ENRICHED MEROPENEM - The present application describes deuterium-enriched meropenem, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-26-2009
20090082323DEUTERIUM-ENRICHED FULVESTRANT - The present application describes deuterium-enriched fulvestrant, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-26-2009
20090082319DEUTERIUM-ENRICHED BUDESONIDE - The present application describes deuterium-enriched budesonide, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-26-2009
20090082318DEUTERIUM-ENRICHED MOMETASONE - The present application describes deuterium-enriched mometasone, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-26-2009
20090082312DEUTERIUM-ENRICHED ZOLEDRONIC ACID - The present application describes deuterium-enriched zoledronic acid, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-26-2009
20090082306DEUTERIUM-ENRICHED TELBIVUDINE - The present application describes deuterium-enriched telbivudine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-26-2009
20090082259DEUTERIUM-ENRICHED OCTREOTIDE - The present application describes deuterium-enriched octreotide, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-26-2009
20090076264DEUTERIUM-ENRICHED RIVAROXABAN - The present application describes deuterium-enriched rivaroxaban, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076167DEUTERIUM-ENRICHED TRAMIPROSATE - The present application describes deuterium-enriched tramiprosate, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076165DEUTERIUM-ENRICHED MEMANTINE - The present application describes deuterium-enriched memantine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076164DEUTERIUM-ENRICHED TAPENTADOL - The present application describes deuterium-enriched tapentadol, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076163DEUTERIUM-ENRICHED DAPOXETINE - The present application describes deuterium-enriched dapoxetine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076162DEUTERIUM-ENRICHED DESVENLAFAXINE - The present application describes deuterium-enriched desvenlafaxine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076161DEUTERIUM-ENRICHED BUPROPION - The present application describes deuterium-enriched bupropion, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076159DEUTERIUM-ENRICHED EPLIVANSERIN - The present application describes deuterium-enriched eplivanserin, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076158DEUTERIUM-ENRICHED BICALUTAMIDE - The present application describes deuterium-enriched bicalutamide, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076157DEUTERIUM-ENRICHED SENICAPOC - The present application describes deuterium-enriched senicapoc, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076154DEUTERIUM-ENRICHED VORINOSTAT - The present application describes deuterium-enriched vorinostat, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076153DEUTERIUM-ENRICHED TIGECYCLINE - The present application describes deuterium-enriched tigecycline, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076150DEUTERIUM-ENRICHED BROMFENAC - The present application describes deuterium-enriched bromfenac, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076148DEUTERIUM-ENRICHED PRAVASTATIN - The present application describes deuterium-enriched pravastatin, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076145DEUTERIUM-ENRICHED AMIBEGRON - The present application describes deuterium-enriched amibegron, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076144DEUTERIUM-ENRICHED BAZEDOXIFENE - The present application describes deuterium-enriched bazedoxifene, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076139DEUTERIUM-ENRICHED OXALPLATIN - The present application describes deuterium-enriched oxaliplatin, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076138DEUTERIUM-ENRICHED DARUNAVIR - The present application describes deuterium-enriched darunavir, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076137DEUTERIUM-ENRICHED DRONEDARONE - The present application describes deuterium-enriched dronedarone, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076135DEUTERIUM-ENRICHED HYDROMORPHONE - The present application describes deuterium-enriched hydromorphone, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076134DEUTERIUM-ENRICHED SIMVASTATIN - The present application describes deuterium-enriched simvastatin, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076133DEUTERIUM-ENRICHED ZANAMIVIR - The present application describes deuterium-enriched zanamivir, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076128DEUTERIUM-ENRICHED TOPIRAMATE - The present application describes deuterium-enriched topiramate, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076127DEUTERIUM-ENRICHED LAROTAXEL - The present application describes deuterium-enriched larotaxel, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076126DEUTERIUM-ENRICHED ENALAPRIL - The present application describes deuterium-enriched alendronate, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076125DEUTERIUM-ENRICHED GLIMEPIRIDE - The present application describes deuterium-enriched glimepiride, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076124DEUTERIUM-ENRICHED ROPINIROLE - The present application describes deuterium-enriched ropinirole, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076121DEUTERIUM-ENRICHED SUMATRIPTAN - The present application describes deuterium-enriched sumatriptan, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076119DEUTERIUM-ENRICHED RAMIPRIL - The present application describes deuterium-enriched ramipril, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076118DEUTERIUM-ENRICHED SAXAGLIPTIN - The present application describes deuterium-enriched saxagliptin, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076117DEUTERIUM-ENRICHED LAROPIPRANT - The present application describes deuterium-enriched laropiprant, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076116DEUTERIUM-ENRICHED CARVEDIOLO - The present application describes deuterium-enriched carvedilol, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076112DEUTERIUM-ENRICHED ELTROMBOPAG - The present application describes deuterium-enriched eltrombopag, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076107DEUTERIUM-ENRICHED ODANSETRON - The present application describes deuterium-enriched ondansetron, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076104DEUTERIUM-ENRICHED LOSARTAN - The present application describes deuterium-enriched losartan, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076102DEUTERIUM-ENRICHED MURAGLITAZAR - The present application describes deuterium-enriched muraglitazar, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076100DEUTERIUM-ENRICHED GSK625433 - The present application describes deuterium-enriched GSK625433, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076099DEUTERIUM-ENRICHED IXABEPILONE - The present application describes deuterium-enriched ixabepilone, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076097DEUTERIUM-ENRICHED ATAZANAVIR - The present application describes deuterium-enriched atazanavir, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076095DEUTERIUM-ENRICHED NICORANDIL - The present application describes deuterium-enriched nicorandil, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076093DEUTERIUM-ENRICHED ROSIGLITAZONE - The present application describes deuterium-enriched rosiglitazone, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076089DEUTERIUM-ENRICHED PANTOPRAZOLE - The present application describes deuterium-enriched pantoprazole, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076087DEUTERIUM-ENRICHED ETORICOXIB - The present application describes deuterium-enriched etoricoxib, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076085DEUTERIUM-ENRICHED NICRAVEN - The present application describes deuterium-enriched nicraven, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076083DEUTERIUM-ENRICHED SAREDUTANT - The present application describes deuterium-enriched saredutant, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076082DEUTERIUM-ENRICHED ALVIMOPAN - The present application describes deuterium-enriched alvimopan, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076080DEUTERIUM-ENRICHED FEXOFENADINE - The present application describes deuterium-enriched fexofenadine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076079DEUTERIUM-ENRICHED METHYLPHENIDATE - The present application describes deuterium-enriched methylphenidate, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076072DEUTERIUM-ENRICHED TAFENOQUINE - The present application describes deuterium-enriched tafenoquine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076071DEUTERIUM-ENRICHED RETAPAMULIN - The present application describes deuterium-enriched retapamulin, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076069DEUTERIUM-ENRICHED APIXABAN - The present application describes deuterium-enriched apixaban, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076066DEUTERIUM-ENRICHED ZOLPIDEM - The present application describes deuterium-enriched zolpidem, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076065DEUTERIUM-ENRICHED MK-0812 - The present application describes deuterium-enriched MK-0812, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076060DEUTERIUM-ENRICHED TEMSIROLIMUS - The present application describes deuterium-enriched temsirolimus, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076059DEUTERIUM-ENRICHED DIANICLINE - The present application describes deuterium-enriched dianicline, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076058DEUTERIUM-ENRICHED FINASTERIDE - The present application describes deuterium-enriched finasteride, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076057DEUTERIUM-ENRICHED DUTASTERIDE - The present application describes deuterium-enriched dutasteride, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076056DEUTERIUM-ENRICHED TOPOTECAN - The present application describes deuterium-enriched topotecan, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076055DEUTERIUM-ENRICHED VINFLUNINE - The present application describes deuterium-enriched vinflunine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076052DEUTERIUM-ENRICHED NALMEFENE - The present application describes deuterium-enriched nalmefene, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076051DEUTERIUM-ENRICHED METHYLNALTREXONE - The present application describes deuterium-enriched methylnatrexone bromide, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076048DEUTERIUM-ENRICHED XALIPRODEN - The present application describes deuterium-enriched xaliproden, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076043DEUTERIUM-ENRICHED ALFUZOSIN - The present application describes deuterium-enriched alfuzosin, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076042DEUTERIUM-ENRICHED ERLOTINIB - The present application describes deuterium-enriched erlotinib, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076040DEUTERIUM-ENRICHED VALGANCICLOVIR - The present application describes deuterium-enriched valganciclovir, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076039DEUTERIUM-ENRICHED VALACYCLOVIR - The present application describes deuterium-enriched valacyclovir, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076038DEUTERIUM-ENRICHED ENTECAVIR - The present application describes deuterium-enriched entecavir, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076036DEUTERIUM-ENRICHED RISPERIDONE - The present application describes deuterium-enriched risperidone, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076035DEUTERIUM-ENRICHED PALIPERIDONE - The present application describes deuterium-enriched peliperidone, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076034DEUTERIUM-ENRICHED BMS-690514 - The present application describes deuterium-enriched BMS-690514, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076031DEUTERIUM-ENRICHED BORTEZOMIB - The present application describes deuterium-enriched bortezomib, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076028DEUTERIUM-ENRICHED ITRACONAZOLE - The present application describes deuterium-enriched itraconazole, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076027DEUTERIUM-ENRICHED LURASIDONE - The present application describes deuterium-enriched lurasidone, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076025DEUTERIUM-ENRICHED DASATINIB - The present application describes deuterium-enriched dasatinib, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076018DEUTERIUM-ENRICHED RANOLAZINE - The present application describes deuterium-enriched ranolazine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076017DEUTERIUM-ENRICHED TRABECTEDIN - The present application describes deuterium-enriched trabectedin, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076013DEUTERIUM-ENRICHED SITAGLIPTIN - The present application describes deuterium-enriched sitagliptin, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076011DEUTERIUM-ENRICHED TIRAPAZAMINE - The present application describes deuterium-enriched tirapazamine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076010DEUTERIUM-ENRICHED LAMOTRIGINE - The present application describes deuterium-enriched lamotrigine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076008DEUTERIUM-ENRICHED FOSAPREPITANT - The present application describes deuterium-enriched fosaprepitant, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076007DEUTERIUM-ENRICHED APREPITANT - The present application describes deuterium-enriched aprepitant, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090076000DEUTERIUM-ENRICHED MYCOPHENOLATE MOFETIL - The present application describes deuterium-enriched mycophenolate mofetil, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090075997DEUTERIUM-ENRICHED SATAVAPTAN - The present application describes deuterium-enriched satavaptan, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090075994DEUTERIUM-ENRICHED RADAFAXINE - The present application describes deuterium-enriched radafaxine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090075991DEUTERIUM-ENRICHED EFAVIRENZ - The present application describes deuterium-enriched efavirenz, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090075977DEUTERIUM-ENRICHED MK0974 - The present application describes deuterium-enriched MK-0974, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090075969DEUTERIUM-ENRICHED DORIPENEM - The present application describes deuterium-enriched doripenem, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090075967DEUTERIUM-ENRICHED CEFTRIAXONE - The present application describes deuterium-enriched ceftriaxone, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090075966DEUTERIUM-ENRICHED TAZOBACTAM - The present application describes deuterium-enriched tazobactam, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090075965DEUTERIUM-ENRICHED AMOXICILIN - The present application describes deuterium-enriched amoxicilin, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090075959DEUTERIUM-ENRICHED CICLESONIDE - The present application describes deuterium-enriched ciclesonide, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090075953DEUTERIUM-ENRICHED ED-71 - The present application describes deuterium-enriched ED-71, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090075947DEUTERIUM-ENRICHED FOSPROPOFOL - The present application describes deuterium-enriched fospropofol, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090075944DEUTERIUM-ENRICHED IBANDRONATE - The present application describes deuterium-enriched ibandronate, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090075942DEUTERIUM-ENRICHED FOSAMPRENAVIR - The present application describes deuterium-enriched fosamprenavir, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090075940DEUTERIUM-ENRICHED RISEDRONATE - The present application describes deuterium-enriched risedronate, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090075931DEUTERIUM-ENRICHED CAPECITABINE - The present application describes deuterium-enriched capecitabine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090075930DEUTERIUM-ENRICHED NELARABINE - The present application describes deuterium-enriched nelarabine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090075920DEUTERIUM-ENRICHED DECITABINE - The present application describes deuterium-enriched decitabine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090075917DEUTERIUM-ENRICHED TELITHROMYCIN - The present application describes deuterium-enriched telithromycin, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090075914DEUTERIUM-ENRICHED ODIPARCIL - The present application describes deuterium-enriched odiparcil, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090075910DEUTERIUM-ENRICHED FONDAPARINUX - The present application describes deuterium-enriched fondaparinux, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090075870DEUTERIUM-ENRICHED CASPOFUNGIN - The present application describes deuterium-enriched caspofungin, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20090069440DEUTERIUM-ENRICHED ATOMOXETINE - The present application describes deuterium-enriched atomoxetine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-12-2009
20090069431DEUTERIUM-ENRICHED MILNACIPRAN - The present application describes deuterium-enriched milnacipran, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-12-2009
20090069415DEUTERIUM-ENRICHED NEBIVOLOL - The present application describes deuterium-enriched nebivolol, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-12-2009
20090069413DEUTERIUM-ENRICHED OLOPATADINE - The present application describes deuterium-enriched olopatadine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-12-2009
20090069412DEUTERIUM-ENRICHED SUGAMMADEX - The present application describes deuterium-enriched sugammadex, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-12-2009
20090069410DEUTERIUM-ENRICHED PACLITAXEL - The present application describes deuterium-enriched paclitaxel, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-12-2009
20090069404DEUTERIUM-ENRICHED VERNAKALANT - The present application describes deuterium-enriched vemakalant, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-12-2009
20090069402DEUTERIUM-ENRICHED ATRASENTAN - The present application describes deuterium-enriched atrasentan, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-12-2009
20090069399DEUTERIUM-ENRICHED FROVATRIPTAN - The present application describes deuterium-enriched frovatriptan, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-12-2009
20090069397DEUTERIUM-ENRICHED OLMESARTAN - The present application describes deuterium-enriched olmesartan, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-12-2009
20090069395DEUTERIUM-ENRICHED FAMOTIDINE - The present application describes deuterium-enriched famotidine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-12-2009
20090069390DEUTERIUM-ENRICHED RUFINAMIDE - The present application describes deuterium-enriched rufinamide, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-12-2009
20090069388DEUTERIUM-ENRICHED SORAFENIB - The present application describes deuterium-enriched sorafenib, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-12-2009
20090069381DEUTERIUM-ENRICHED RALOXIFENE - The present application describes deuterium-enriched raloxifene, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-12-2009
20090069380DEUTERIUM-ENRICHED AROXIFENE - The present application describes deuterium-enriched arzoxifene, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-12-2009
20090069379DEUTERIUM-ENRICHED LENALIDOMIDE - The present application describes deuterium-enriched lenalidomide, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-12-2009
20090069378DEUTERIUM-ENRICHED DONEPEZIL - The present application describes deuterium-enriched donepezil, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-12-2009
20090069377DEUTERIUM-ENRICHED ENZASTAURIN - The present application describes deuterium-enriched enzastaurin, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-12-2009
20090069375DEUTERIUM-ENRICHED MIGLUSTAT - The present application describes deuterium-enriched miglustat, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-12-2009
20090069369DEUTERIUM-ENRICHED PRASUGREL - The present application describes deuterium-enriched prasugrel, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-12-2009
20090069366DEUTERIUM-ENRICHED TACROLIMUS - The present application describes deuterium-enriched tacrolimus, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-12-2009
20090069357DEUTERIUM-ENRICHED ICLAPRIM - The present application describes deuterium-enriched iclaprim, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-12-2009
20090069354DEUTERIUM-ENRICHED GEMCITABINE - The present application describes deuterium-enriched gemcitabine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-12-2009
20090069353DEUTERIUM-ENRICHED AMBRISENTAN - The present application describes deuterium-enriched ambrisentan, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-12-2009
20090069352DEUTERIUM-ENRICHED CLAZOSENTAN - The present application describes deuterium-enriched clazosentan, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-12-2009

Patent applications by PROTIA, LLC